Canada markets closed

Addex Therapeutics Ltd (ADXN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.4400+0.1900 (+15.20%)
At close: 04:00PM EST
1.4000 -0.04 (-2.78%)
After hours: 07:55PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) 22.65M
Enterprise Value 11.76M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.72
Price/Book (mrq)2.57
Enterprise Value/Revenue 9.58
Enterprise Value/EBITDA -0.56

Trading Information

Stock Price History

Beta (5Y Monthly) 1.52
52-Week Change 3-77.23%
S&P500 52-Week Change 3-6.78%
52 Week High 36.2400
52 Week Low 30.5500
50-Day Moving Average 30.7739
200-Day Moving Average 31.5987

Share Statistics

Avg Vol (3 month) 3203.28k
Avg Vol (10 day) 3278.14k
Shares Outstanding 519.22M
Implied Shares Outstanding 6N/A
Float 84.02M
% Held by Insiders 10.00%
% Held by Institutions 147.44%
Shares Short (Jan 12, 2023) 451.68k
Short Ratio (Jan 12, 2023) 40.44
Short % of Float (Jan 12, 2023) 4N/A
Short % of Shares Outstanding (Jan 12, 2023) 40.27%
Shares Short (prior month Dec 14, 2022) 434.86k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CHF.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,707.44%

Management Effectiveness

Return on Assets (ttm)-87.86%
Return on Equity (ttm)-202.67%

Income Statement

Revenue (ttm)1.25M
Revenue Per Share (ttm)0.19
Quarterly Revenue Growth (yoy)-45.10%
Gross Profit (ttm)-9.69M
EBITDA -21.51M
Net Income Avi to Common (ttm)-21.58M
Diluted EPS (ttm)-3.2640
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)10.42M
Total Cash Per Share (mrq)1.18
Total Debt (mrq)447.11k
Total Debt/Equity (mrq)5.62
Current Ratio (mrq)2.83
Book Value Per Share (mrq)0.90

Cash Flow Statement

Operating Cash Flow (ttm)-16.31M
Levered Free Cash Flow (ttm)-8.23M